share_log

Neumora Therapeutics Has Initiated A Phase 1 Single Ascending Dose / Multiple Ascending Dose Study Of NMRA-266 In Healthy Adult Participants For Schizophrenia And Other Neuropsychiatric Disorders

Neumora Therapeutics Has Initiated A Phase 1 Single Ascending Dose / Multiple Ascending Dose Study Of NMRA-266 In Healthy Adult Participants For Schizophrenia And Other Neuropsychiatric Disorders

Neumora Therapeutics 已启动一项针对精神分裂症和其他神经精神疾病的健康成年参与者 NMRA-266 的 1 期单剂量递增剂量/多剂量递增剂量研究
Benzinga ·  2023/11/27 07:13

Neumora Therapeutics Has Initiated A Phase 1 Single Ascending Dose / Multiple Ascending Dose Study Of NMRA-266 In Healthy Adult Participants For Schizophrenia And Other Neuropsychiatric Disorders

Neumora Therapeutics 已启动一项针对精神分裂症和其他神经精神疾病的健康成年参与者 NMRA-266 的 1 期单剂量递增剂量/多剂量递增剂量研究

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发